IP Verse

Protein Purification And Virus Inactivation With Alkyl Glycosides - EP3728287

The patent EP3728287 was granted to CSL Behring Lengnau on Apr 10, 2024. The application was originally filed on Dec 19, 2018 under application number EP18826000A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3728287

CSL BEHRING LENGNAU
Application Number
EP18826000A
Filing Date
Dec 19, 2018
Status
Granted And Under Opposition
Mar 8, 2024
Grant Date
Apr 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MARGARET DIXONJan 9, 2025MEWBURN ELLISADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2015073633
DESCRIPTIONWO2016188907
INTERNATIONAL-SEARCH-REPORTAU2015204304B
INTERNATIONAL-SEARCH-REPORTCA2228031
INTERNATIONAL-SEARCH-REPORTEP1578443
INTERNATIONAL-SEARCH-REPORTUS2003049819
INTERNATIONAL-SEARCH-REPORTUS2010216161
INTERNATIONAL-SEARCH-REPORTUS5432069
INTERNATIONAL-SEARCH-REPORTUS5759855
INTERNATIONAL-SEARCH-REPORTWO2015073633
INTERNATIONAL-SEARCH-REPORTWO2019028186
INTERNATIONAL-SEARCH-REPORTWO9727873
INTERNATIONAL-SEARCH-REPORTWO9802557
OPPOSITIONUS2003049819
OPPOSITIONUS2010216161
OPPOSITIONUS5432069
OPPOSITIONUS6174704
OPPOSITIONWO2009024620
OPPOSITIONWO2015073633
OPPOSITIONWO2016188907
OPPOSITIONWO2019028186
OPPOSITIONWO2019121846
OPPOSITIONWO9623061

Non-Patent Literature (NPL) Citations (27) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALMEIDA; ALPAR, J. Drug Targeting, (19960000), vol. 3, pages 455 - 467-
DESCRIPTION- "Annex 4 Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products Series", WHO Technical Report, (20040000), pages 151 - 224-
DESCRIPTION- BOSLEY et al., Proteomics Clin Appl, (20080000), vol. 2, no. 6, pages 904 - 7-
DESCRIPTION- GRONER et al., Transfusion, (20120000), vol. 52, pages 2104 - 2112-
DESCRIPTION- JOHNSTON et al., Biologicals, (20030000), vol. 31, no. 3, pages 213 - 21-
DESCRIPTION- KORNEYEVA et al., Biologicals, (20020000), vol. 30, no. 2, pages 153 - 62-
DESCRIPTION- LEBING et al., Vox Sang, (20030000), vol. 84, no. 3, pages 193 - 201-
DESCRIPTION- "Pharmaceutical Process Filtration Catalogue", Millipore catalogue, (19950000), pages 177 - 202-
DESCRIPTION- ROBERTS, Biologicals, (20000000), vol. 28, pages 29 - 32-
EXAMINATION- V. Brass ET AL, "Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex", Proceedings of the National Academy of Sciences, (20080923), vol. 105, no. 38, doi:10.1073/pnas.0807298105, ISSN 0027-8424, pages 14545 - 14550, XP055454378
INTERNATIONAL-SEARCH-REPORT- GARG H ET AL, "Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 80, no. 1, doi:10.1016/J.ANTIVIRAL.2008.04.004, ISSN 0166-3542, (20081001), pages 54 - 61, (20080827), XP024339830 [X] 16-21,25,29-31 * whole document, in particular section 2.8, 2.4 *
INTERNATIONAL-SEARCH-REPORT- STEWART BACHAN ET AL, "Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 19, no. 16, doi:10.1016/J.BMC.2011.06.078, ISSN 0968-0896, (20110627), pages 4803 - 4811, (20110701), XP028252899 [X] 16-21,25,29-31 * whole document, in particular section 2.2, 2.5 *
OPPOSITION- Anonymous, "ChromAtography Macro-Prep® High Q Support: Achieve High Productivity Using Macro-Prep High Q Anion Exchange Support", Bio-Rad Bulletin, (20071116), no. 5644, pages 1 - 2, XP009561087-
OPPOSITION- Anonymous, "GE Healthcare' MonoQ HR 5/5 column", Biocompare, (20000729), pages 1 - 1, Biocompare , URL: https://www.biocompare.com/Product-Reviews/40365-GE-Healthcare-MonoQ-HR-5-5-column/, (20241209), XP093253263-
OPPOSITION- Anonymous, "MabSelect SuRe Cytiva 17-5438-02, pack of 200 mL", Sigma aldrich - Sigma aldrich, (20230424), pages 1 - 7, Sigma aldrich - Sigma aldrich, URL: https://www.sigmaaldrich.com/NL/en/product/sigma/ge17543802?srsltid=AfmBOopZgFU2JCtqOKhbaKtuXZKFGmrfAd0aMXWSuiIJc8vJg1_nzyp8, XP009561085-
OPPOSITION- Anonymous, "Product Specification Decyl β-D-glucopyranoside", Product Specification, Aigma Aldrich, (20250310), pages 1 - 1, Product Specification, URL: https://www.sigmaaldrich.com/NL/en/product/sigma/d5394#product-documentation, XP093275940-
OPPOSITION- Anonymous, "Protein A PhyTip Columns", Biotage Datasheet, Biotage, (20240101), pages 1 - 3, XP009561086-
OPPOSITION- Anonymous, "Sigma Datasheet - CAS 110615-47-9 Mackol DG", Sigma Aldrich, (20240719), pages 1 - 12, XP093253245-
OPPOSITION- Anonymous, "Sigma Datasheet - Triton CG-100", Sigma-Aldrich, (20241015), pages 1 - 13, XP093253240-
OPPOSITION- Anonymous, "Technical Data Sheet APG 325N", BASF, (20191001), pages 1 - 2, XP093253249-
OPPOSITION- Kan Alison; Mohamedali Abidali; Tan Sock Hwee; Cheruku Harish R.; Slapetova Iveta; Lee Ling Y.; Baker Mark S., "An improved method for the detection and enrichment of low-abundant membrane and lipid raft-residing proteins", Journal of Proteomics, AMSTERDAM, NL , (20121129), vol. 79, doi:10.1016/j.jprot.2012.11.019, ISSN 1874-3919, pages 299 - 304, XP028983854
OPPOSITION- Ulf Sivars , Jeff Abramson , So Iwata , Folke Tjerneld, "Affinity partitioning of a poly(histidine)-tagged integral membrane protein, cytochrome bo"3 ubiquinol oxidase, in a detergent-polymer aqueous two-phase system containing metal-chelating polymer", Journal of Chromatography B, NL , (20000623), vol. 743, no. 1-2, doi:10.1016/S0378-4347(00)00113-4, ISSN 0378-4347, pages 307 - 316, XP027432456
OPPOSITION- Stearns, Tim, "Green Flourescent Protein: The green revolution", Current Biology, GB , (19950301), vol. 5, no. 3, doi:10.1016/S0960-9822(95)00056-X, ISSN 0960-9822, pages 262 - 264, XP004585357
OPPOSITION- Zemanová Lenka, Peter-Katalinic Jasna, König Simone, Wagner Gerlinde, Ziegler Paul, "Post-translational N- and C-terminal processing in the development of wheat leaf B-amylase polymorphism from an hitherto undetected primary gene product", Plant Physiology and Biochemistry, AMSTERDAM, NL , (20020201), vol. 40, no. 2, doi:10.1016/S0981-9428(01)01359-6, ISSN 0981-9428, pages 101 - 109, XP093253221
OPPOSITION- Herter Stefan M., Schiltz Emile, Drews Gerhart, "Protein and Gene Structure of the NADH‐Binding Fragment of Rhodobacter Capsulatus NADH: Ubiquinone Oxidoreductase", European Journal of Biochemistry, Hoboken, USA, (19970601), vol. 246, no. 3, doi:10.1111/j.1432-1033.1997.t01-1-00800.x, ISSN 0014-2956, pages 800 - 808, XP093253223
OPPOSITION- Raza Haider, "Dual localization of glutathione S ‐transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease", The FEBS Journal, GB , (20111101), vol. 278, no. 22, doi:10.1111/j.1742-4658.2011.08358.x, ISSN 1742-464X, pages 4243 - 4251, XP093253227
OPPOSITION- Hirofumi Tani, Tamio Kamidate , Hiroto Watanabe, "Aqueous Micellar Two-Phase Systems for Protein Separation", Analytical Sciences, JP , (19980101), vol. 14, doi:10.2116/analsci.14.875, ISSN 0910-6340, pages 875 - 888, XP000941015

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents